Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Return on Capital Employed (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Return on Capital Employed for 4 consecutive years, with 1.52% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 11.0% to 1.52% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.52%, a 11.0% decrease, with the full-year FY2025 number at 0.94%, up 1.0% from a year prior.
  • Return on Capital Employed was 1.52% for Q4 2025 at Spruce Biosciences, up from 5.41% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.46% in Q2 2023 to a low of 5.41% in Q3 2025.
  • A 4-year average of 1.42% and a median of 0.71% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -1bps in 2023, then tumbled -467bps in 2025.
  • Spruce Biosciences' Return on Capital Employed stood at 0.61% in 2022, then decreased by -2bps to 0.62% in 2023, then tumbled by -127bps to 1.41% in 2024, then dropped by -8bps to 1.52% in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Return on Capital Employed are 1.52% (Q4 2025), 5.41% (Q3 2025), and 2.71% (Q2 2025).